Examining chronic kidney disease screening frequency among diabetics: a POMDP approach
Health Care Management Science · 2024-09 · 27 (3) · 391-414
DOI: 10.1007/s10729-024-09677-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Health Care Management Science, online erschienen am 05.06.2024. Verfasst von Chou-Chun Wu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Daniel J. Epstein Department of Industrial and Systems Engineering, University of Southern California, Los Angeles, CA, USA. chouchuw@usc.edu. Hauptthemen laut MEDLINE: Markov Chains, Renal Insufficiency, Chronic, Mass Screening. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Forty percent of diabetics will develop chronic kidney disease (CKD) in their lifetimes. However, as many as 50% of these CKD cases may go undiagnosed. We developed screening recommendations stratified by age and previous test history for individuals with diagnosed diabetes and unknown proteinuria status by race and gender groups. To do this, we used a Partially Observed Markov Decision Process (POMDP) to identify whether a patient should be screened at every three-month interval from ages 30-85. Model inputs were drawn from nationally-representative datasets, the medical literature, and a microsimulation that integrates this information into group-specific disease progression rates. We implement the POMDP solution policy in the microsimulation to understand how this policy may impact health outcomes and generate an easily-implementable, non-belief-based approximate policy for easier clinical interpretability. We found that the status quo policy, which is to screen annually for all ages and races, is suboptimal for maximizing expected discounted future net monetary benefits (NMB). The POMDP policy suggests more frequent screening after age 40 in all race and gender groups, with screenings 2-4 times a year for ages 61-70. Black individuals are recommended for screening more frequently than their White counterparts. This policy would increase NMB from the status quo policy between $1,000 to $8,000 per diabetic patient at a willingness-to-pay of $150,000 per quality-adjusted life year (QALY).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Daniel J. Epstein Department of Industrial and Systems Engineering, University of Southern California, Los Angeles, CA, USA. chouchuw@usc.edu.
- Daniel J. Epstein Department of Industrial and Systems Engineering, University of Southern California, Los Angeles, CA, USA.
- Department of Medicine, Division of Nephrology, University of Southern California, Los Angeles, CA, USA.
- Leonard D. Schaeffer Center for Health Policy & Economics, University of Southern California, Los Angeles, CA, USA.
Förderung
- NIDDK NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Wu, C. C., Cao, Y., Suen, S. C., & Lin, E. (2024). Examining chronic kidney disease screening frequency among diabetics: a POMDP approach. Health Care Management Science, 27(3), 391-414. https://doi.org/10.1007/s10729-024-09677-4
Vancouver
Wu CC, Cao Y, Suen SC, Lin E. Examining chronic kidney disease screening frequency among diabetics: a POMDP approach. Health Care Management Science. 2024;27(3):391-414. doi:10.1007/s10729-024-09677-4
BibTeX
@article{Wu2024,
author = {Wu, Chou-Chun and Cao, Yiwen and Suen, Sze-Chuan and Lin, Eugene},
title = {Examining chronic kidney disease screening frequency among diabetics: a POMDP approach},
journal = {Health Care Management Science},
year = {2024},
volume = {27},
number = {3},
pages = {391--414},
doi = {10.1007/s10729-024-09677-4}
}
EUVIMED